JP2002514404A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514404A5
JP2002514404A5 JP2000548371A JP2000548371A JP2002514404A5 JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5 JP 2000548371 A JP2000548371 A JP 2000548371A JP 2000548371 A JP2000548371 A JP 2000548371A JP 2002514404 A5 JP2002514404 A5 JP 2002514404A5
Authority
JP
Japan
Prior art keywords
polypeptide
composition
conjugated
patient
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000548371A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514404A (ja
JP4542705B2 (ja
Filing date
Publication date
Priority claimed from AUPP3450A external-priority patent/AUPP345098A0/en
Application filed filed Critical
Publication of JP2002514404A publication Critical patent/JP2002514404A/ja
Publication of JP2002514404A5 publication Critical patent/JP2002514404A5/ja
Application granted granted Critical
Publication of JP4542705B2 publication Critical patent/JP4542705B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000548371A 1998-05-11 1999-05-07 オーストラリア・ブラウン・スネーク，プソイドナジャ・テキスティリス・テキスティリスからのプラスミンインヒビター Expired - Fee Related JP4542705B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP3450A AUPP345098A0 (en) 1998-05-11 1998-05-11 Novel anti-fibrinolytic agents
AU3450 1998-05-11
PCT/AU1999/000343 WO1999058569A1 (en) 1998-05-11 1999-05-07 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)

Publications (3)

Publication Number Publication Date
JP2002514404A JP2002514404A (ja) 2002-05-21
JP2002514404A5 true JP2002514404A5 (enExample) 2006-07-13
JP4542705B2 JP4542705B2 (ja) 2010-09-15

Family

ID=3807704

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548371A Expired - Fee Related JP4542705B2 (ja) 1998-05-11 1999-05-07 オーストラリア・ブラウン・スネーク，プソイドナジャ・テキスティリス・テキスティリスからのプラスミンインヒビター

Country Status (11)

Country Link
US (1) US7070969B1 (enExample)
EP (1) EP1078003B1 (enExample)
JP (1) JP4542705B2 (enExample)
AT (1) ATE440108T1 (enExample)
AU (1) AUPP345098A0 (enExample)
CA (1) CA2328431C (enExample)
DE (1) DE69941292D1 (enExample)
DK (1) DK1078003T3 (enExample)
ES (1) ES2332249T3 (enExample)
NZ (1) NZ508770A (enExample)
WO (1) WO1999058569A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents
US6506365B1 (en) * 2000-09-25 2003-01-14 Baxter Aktiengesellschaft Fibrin/fibrinogen binding conjugate
US7745192B2 (en) 2002-04-03 2010-06-29 Venomics Pty Limited Prothrombin activating protein
ES2431526T3 (es) 2005-12-29 2013-11-26 The Regents Of The University Of California Office Of Technology Transfer Procedimientos y composiciones relacionadas con el dominio Kunitz I mutante de TFPI-2
EP2154152A1 (en) * 2008-08-08 2010-02-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Use of Conkunitzin-S1 for the modulation of glucose-induced insulin secretion
EP2359852A4 (en) * 2008-11-17 2015-05-20 Nat Cancer Ct NEW CANCERED THERAPY WITH A SUBSTANCE COMPLEX SPECIFICALLY BINDING TO A TUMOR STREAM FACTOR AND ANTITUMIR COMPOUND
CN102850451B (zh) * 2011-06-29 2014-05-07 辽宁诺康生物制药有限责任公司 具有抑制纤溶酶活性的重组textilinin-1及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
EP0585504A1 (en) * 1992-09-04 1994-03-09 Pentapharm A.G. Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing
AUPP076797A0 (en) * 1997-12-05 1998-01-08 Active (Pla) R&D Pty Ltd Phospholipase inhibitor
AUPP345098A0 (en) * 1998-05-11 1998-06-04 National Institute Of Biological Standards And Control, United Kingdom Novel anti-fibrinolytic agents

Similar Documents

Publication Publication Date Title
WO2005081711A3 (en) Monomethylvaline compounds capable of conjugation to ligands
CA2267456A1 (en) Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
MY129356A (en) Electrospun pharmaceutical compositions
CA2360248A1 (en) Combinations of formoterol and a tiotropium salt
JP2003505345A5 (enExample)
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
WO1998001158A3 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
FR2791678B1 (fr) Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
PT1214077E (pt) Libertacao local de estradiol 17-beta para melhorar a funcao vascular do endotelio na sequencia de feridas vasculares
WO1999044608A8 (en) New use
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
JP2002542248A5 (enExample)
JP2002522501A5 (enExample)
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
JP2002514404A5 (enExample)
JP2001513504A5 (enExample)
JP2004500325A5 (enExample)
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
EP0931545A3 (en) Droloxifene pharmaceutical compositions
WO2003037272A3 (en) Thymosin alpha 1 peptide/polymer conjugates
CA2337667A1 (en) Dextran-leptin conjugates, pharmaceutical compositions and related methods
CA2373252A1 (en) Long lasting anti-angiogenic peptides
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.